CLNN

NASD Clene Inc
Oct 16, 2026 · 10:27 PM ET EOD Market Closed

$3.10 ↑ +0.00 (+0.00%) Trading Up from the previous close of $3.10, $0.29 below the day’s high of $3.39

YTD change
-47.19%
vs 20-day SMA
-22.05%
vs 200-day SMA
-41.45%

Price ranges

Previous day
$3.20 $3.44
open $3.25 close $3.31
+$0.06 (+1.69%)
Today
$3.02 $3.39
open $3.26 now $3.10
-$0.16 (-4.91%)
Past week
$3.20 $3.96
from $3.88 now $3.10
-$0.78 (-20.10%)
Past month
$3.20 $4.70
from $4.15 now $3.10
-$1.05 (-25.30%)
This year
$3.02 $8.67
from $5.87 now $3.10
-$2.77 (-47.19%)

Price & Performance

-3.25 (-51.18%) / 6M

$2.70$4.63$6.56$8.49Apr 16Jul 17Oct 16

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 99.1% away from all-time highs of $356.40
  • CLNN is down 47% since the beginning of the year
  • CLNN is down 62% over the past 12 months
  • CLNN is down 25% over the past 1 month
  • 7% of all CLNN investors are betting against CLNN

CLNN reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -62.4%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-1.08
Earnings momentum -137.9% Quarterly EPS growth
Quarterly change -137.9%

Valuation

P/E ratio N/A
Enterprise value $53.6M
Beta 0.93

Balance sheet & scale

IncomeN/A
Revenue$197.0K
Cash$9.7M
Debt$22.3K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $44.1M

Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded in 2013 and is headquartered in Salt Lake City, UT.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $432.49 -0.35%
MRNA Moderna, Inc. $218.01 -7.82%
RVMD Revolution Medicines, Inc. $177.96 -5.97%
ROIV Roivant Sciences Ltd. $33.53 -1.50%
BNTX BioNTech SE Sponsored ADR $87.71 -2.76%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.